Design Therapeutics (DSGN) Operating Expenses: 2020

Historic Operating Expenses for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to $8.6 million.

  • Design Therapeutics' Operating Expenses was N/A to $3.9 million in Q4 2020 from the same period last year, while for Dec 2020 it was $8.6 million, marking a year-over-year change of. This contributed to the annual value of $8.6 million for FY2020, which is N/A change from last year.
  • Design Therapeutics' Operating Expenses amounted to $8.6 million in FY2020.
  • In the past 5 years, Design Therapeutics' Operating Expenses registered a high of $8.6 million during FY2020, and its lowest value of $8.6 million during FY2020.
  • Over the past 1 years, Design Therapeutics' median Operating Expenses value was $8.6 million (recorded in 2020), while the average stood at $8.6 million.